IASLC Newsletter - March 2018
Scientific Speed Dating and "Hope with Answers"
Lysa Buonanno, Lung Cancer Survivor and Advocate | @lysabee
I recently attended my second IASLC Lung Cancer Targeted Therapies Meeting (#TTLC18), sponsored by the IASLC. Attendance is by invitation only and is geared toward those that work in the lung cancer arena. Other advocates have referred to the meeting as “scientific speed dating,” as it is very fast paced with presentations being five minutes or less. The presenters summarize the data on new targeted therapies and immunotherapies - most of which is new and unpublished information.
As a lung cancer survivor and advocate, I was honored to meet and talk with several great oncologists and researchers. Thanks to @IASLC and @lcfamerica, I participated in a new patient-led video conversation with oncologists called Hope With Answers along with three other survivors/advocates: @GoldmanLisa, @JFreemanDaily and Allen Fremont.
We covered several topics that were separated into segments for three different types of patients: the newly diagnosed, those with a basic knowledge, and those with a more in-depth knowledge of lung cancer and its treatments. These videos, along with information shared by patients, advocates and experts in the field through social media channels, is useful for the many patients who don’t have access to specialists in their region. We look forward to having more doctors and patients participate in the future.
March 2018: The IASLC and the Journal of Thoracic Oncology (JTO) are pleased to present the Editor's Choice each month to highlight certain articles of interest. The articles below from the March 2018 issue of the JTO are free for three months. Please share with your colleagues around the globe!
Alex A. Adjei, MD, PhD
By Ferrara et al.
Dr Adjei points out in the accompanying editorial that there will be future reviews on other areas of thoracic oncology.
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
By Lindeman et al.
The Addition of Chemotherapy to Radiation Therapy Improves Survival in Elderly Patients with Stage III Non–Small Cell Lung Cancer
By Miller et al.
Non-member Survey - Please Share
Do you have a colleague that is not yet an IASLC member? Help them win free registration for this year’s WCLC by participating in our non-member survey. Please share this link with your colleagues and contacts in lung cancer to help us collect feedback about our benefits, programs and services.
Free Membership for Patients/Survivors/Caregivers
Patients/survivors/caregivers can renew this non-voting membership annually. Except for voting, the patient/survivor/caregiver membership includes all Allied Health Professional member benefits. It also includes online access to the JTO, member meeting discounts, eligibility to apply for travel awards and eligibility to serve on IASLC committees. Register as Patient/Survivor/Caregiver.
Member Account Information
It’s important for the IASLC to keep our records up to date so that members can receive important information via email and postal letter. To ensure that our records are current, please sign into your IASLC account to edit any details that may need updating. You can always email updates to firstname.lastname@example.org or call +1 720-598-1949.
Welcome New IASLC Members
Welcome to all new IASLC members who joined during February 2018.
Lung Cancer Awareness Month (LCAM) 2018
To continue building on the momentum of the 2017 Lung Cancer Awareness Month Coalition (LCAMC) harmonized strategy, the IASLC held a kickoff meeting in Santa Monica, California, during the IASLC 18th Annual Targeted Therapies of the Treatment of Lung Cancer Meeting. At the meeting, we fleshed out our goals for this year, which include further developing our campaign's website, building on the success of donated ad space and continuing to leverage support from our partners and sponsors.
The LCAM website is a year-round resource to read stories of those affected by lung cancer. The lung cancer community can participate by submitting personal stories to be included in the site. You can also sign up on the site to receive email updates about its continuing development and follow the campaign on Facebook and Twitter feeds that are specifically devoted to the campaign.
If your organization would like to be an LCAM 2018 partner, please contact Kristin.Schultz@iaslc.org. Thank you to our partners who have recently joined the campaign, including the IASLC Foundation, Ride Hard. Breath Easy and the EGFR Resisters.
IASLC Foundation Cancer Care Team Award Nomination Form – NOW OPEN
We're excited to announce that the nomination period is open for the IASLC Foundation Cancer Care Team Award. Now in its second year, this award is designed to recognize outstanding patient care and aims to honor multidisciplinary teams working together to provide the highest quality cancer care.
Nominations for this award will be accepted from all over the world. The winning team will select one representative to attend the IASLC 19th World Conference on Lung Cancer (#WCLC2018) in Toronto, Canada. Learn more and nominate a team for the award.
2018 WCLC Advocacy Travel Award Application – NOW OPEN
Patient advocates and advocacy organizations can now apply for IASLC Patient Advocacy Travel Awards, which provide free registration and travel expense stipends for up to five patient advocates for the IASLC 19th World Conference on Lung Cancer (#WCLC2018) held September 23 - 26, 2018, in Toronto, Canada.
Advocacy travel award applicants are required to submit:
The award is open to organizations that can show 501(c)(3) or a similar type of non-profit status, and to individuals not affiliated with an advocacy organization. Find more information on the official website of the IASLC 19th World Conference on Lung Cancer.
The Lung Cancer Registry – OPEN for Patient Participation
The Lung Cancer Registry was started by the Bonnie J. Addario Lung Cancer Foundation and hopes to build a comprehensive data repository to help researchers and clinicians better identify and understand the complexities of this disease. Patients and/or caregivers on behalf of patients can participate. The IASLC is a contributing partner for this initiative. Learn more about how you can help.
Become a Member
Join the only international association solely dedicated to lung cancer research and treatment.
September 7 - 10 2019Barcelona, Spain
October 10 - 12 2019Chicago, Illinois
October 17 - 19 2019Mexico City, Mexico